BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21270147)

  • 1. Cytomegalovirus capsid protease: biological substrates are cleaved more efficiently by full-length enzyme (pUL80a) than by the catalytic domain (assemblin).
    Fernandes SM; Brignole EJ; Taori K; Gibson W
    J Virol; 2011 Apr; 85(7):3526-34. PubMed ID: 21270147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.
    Brignole EJ; Gibson W
    J Virol; 2007 Apr; 81(8):4091-103. PubMed ID: 17287260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions.
    Chan CK; Brignole EJ; Gibson W
    J Virol; 2002 Sep; 76(17):8667-74. PubMed ID: 12163586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine.
    Welch AR; McNally LM; Hall MR; Gibson W
    J Virol; 1993 Dec; 67(12):7360-72. PubMed ID: 8230459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical rescue of I-site cleavage in living cells and in vitro discriminates between the cytomegalovirus protease, assemblin, and its precursor, pUL80a.
    McCartney SA; Brignole EJ; Kolegraff KN; Loveland AN; Ussin LM; Gibson W
    J Biol Chem; 2005 Sep; 280(39):33206-12. PubMed ID: 16036911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus protein substrates are not cleaved by the herpes simplex virus type 1 proteinase.
    Welch AR; Villarreal EC; Gibson W
    J Virol; 1995 Jan; 69(1):341-7. PubMed ID: 7983728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assemblin homolog of herpes simplex virus type 1 retains proteolytic activity when expressed as a recombinant two-chain enzyme.
    Hall MR; Gibson W
    Virology; 1997 Jan; 227(1):160-7. PubMed ID: 9007069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus assemblin: the amino and carboxyl domains of the proteinase form active enzyme when separately cloned and coexpressed in eukaryotic cells.
    Hall MR; Gibson W
    J Virol; 1996 Aug; 70(8):5395-404. PubMed ID: 8764050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites.
    Burck PJ; Berg DH; Luk TP; Sassmannshausen LM; Wakulchik M; Smith DP; Hsiung HM; Becker GW; Gibson W; Villarreal EC
    J Virol; 1994 May; 68(5):2937-46. PubMed ID: 8151764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of human cytomegalovirus protease pUL80a at internal and cryptic sites is not essential but enhances infectivity.
    Loveland AN; Chan CK; Brignole EJ; Gibson W
    J Virol; 2005 Oct; 79(20):12961-8. PubMed ID: 16188998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant full-length human cytomegalovirus protease has lower activity than recombinant processed protease domain in purified enzyme and cell-based assays.
    Wittwer AJ; Funckes-Shippy CL; Hippenmeyer PJ
    Antiviral Res; 2002 Aug; 55(2):291-306. PubMed ID: 12103430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus proteinase: candidate glutamic acid identified as third member of putative active-site triad.
    Cox GA; Wakulchik M; Sassmannshausen LM; Gibson W; Villarreal EC
    J Virol; 1995 Jul; 69(7):4524-8. PubMed ID: 7769716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide substrate cleavage specificity of the human cytomegalovirus protease.
    Sardana VV; Wolfgang JA; Veloski CA; Long WJ; LeGrow K; Wolanski B; Emini EA; LaFemina RL
    J Biol Chem; 1994 May; 269(20):14337-40. PubMed ID: 8182034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independently cloned halves of cytomegalovirus assemblin, An and Ac, can restore proteolytic activity to assemblin mutants by intermolecular complementation.
    Hall MR; Gibson W
    J Virol; 1997 Feb; 71(2):956-64. PubMed ID: 8995613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino-conserved domain of human cytomegalovirus UL80a proteins is required for key interactions during early stages of capsid formation and virus production.
    Loveland AN; Nguyen NL; Brignole EJ; Gibson W
    J Virol; 2007 Jan; 81(2):620-8. PubMed ID: 17079329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization sequences in cytomegalovirus capsid assembly proteins (UL80 proteins) are required for virus production: inactivating NLS1, NLS2, or both affects replication to strikingly different extents.
    Nguyen NL; Loveland AN; Gibson W
    J Virol; 2008 Jun; 82(11):5381-9. PubMed ID: 18353959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.
    Stevens JT; Mapelli C; Tsao J; Hail M; O'Boyle D; Weinheimer SP; Diianni CL
    Eur J Biochem; 1994 Dec; 226(2):361-7. PubMed ID: 8001553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particles.
    Weinheimer SP; McCann PJ; O'Boyle DR; Stevens JT; Boyd BA; Drier DA; Yamanaka GA; DiIanni CL; Deckman IC; Cordingley MG
    J Virol; 1993 Oct; 67(10):5813-22. PubMed ID: 8396657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective inhibition of human cytomegalovirus gene expression and growth by intracellular expression of external guide sequence RNA.
    Li H; Trang P; Kim K; Zhou T; Umamoto S; Liu F
    RNA; 2006 Jan; 12(1):63-72. PubMed ID: 16301604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics.
    LaFemina RL; Bakshi K; Long WJ; Pramanik B; Veloski CA; Wolanski BS; Marcy AI; Hazuda DJ
    J Virol; 1996 Jul; 70(7):4819-24. PubMed ID: 8676515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.